The impact of diagnostic changes on the rise in thyroid cancer incidence: A population-based study in selected high-resource countries

Thyroid

Volumn 25, Issue 10, 2015, Pages 1127-1136

  Vaccarella, Salvatore ^a   Dal Maso, Luigino ^b   Laversanne, Mathieu ^a   Bray, Freddie ^a   Plummer, Martyn ^a   Franceschi, Silvia ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; AUSTRALIA; CANCER INCIDENCE; CARCINOGENESIS; ECHOGRAPHY; FEMALE; FRANCE; HUMAN; ITALY; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SOUTH KOREA; THYROID CANCER; UNITED KINGDOM; UNITED STATES; HEALTH SERVICE; INCIDENCE; MIDDLE AGED; REGISTER; THYROID NEOPLASMS; TRENDS; YOUNG ADULT;

ADULT; AGED; FEMALE; HUMANS; INCIDENCE; MALE; MEDICAL OVERUSE; MIDDLE AGED; REGISTRIES; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84942753966     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2015.0116     Document Type: Article

References (48)

1. La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F, Negri E 2015 Thyroid cancer mortality and incidence: a global overview. Int J Cancer 136: 2187-2195
2. Franceschi S, Vaccarella S 2015 Thyroid cancer: An epidemic of disease or an epidemic of diagnosis?. Int J Cancer 136: 2738-2739
3. Dal Maso L, Lise M, Zambon P, Falcini F, Crocetti E, Serraino D, Cirilli C, Zanetti R, Vercelli M, Ferretti S, Stracci F, De Lisi V, Busco S, Tagliabue G, Budroni M, Tumino R, Giacomin A, Franceschi S 2011 Incidence of thyroid cancer in Italy, 1991-2005: time trends and ageperiod-cohort effects. Ann Oncol 22: 957-963
4. Binder-Foucard F, Bossard N, Delafosse P, Belot A, Woronoff AS, Remontet L 2014 Cancer incidence and mortality in France over the 1980-2012 period: solid tumors. Rev Epidemiol Sante Publique 62: 95-108
5. Brito JP, Morris JC, Montori VM 2013 Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours. BMJ 347: f4706
6. Davies L, Welch HG 2014 Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 140: 317-322
7. Chen AY, Jemal A, Ward EM 2009 Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 115: 3801-3807
8. Ahn HS, Kim HJ, Welch HG 2014 Koreas thyroid-cancer epidemic-screening and overdiagnosis. N Engl J Med 371: 1765-1767
9. Esserman LJ, Thompson IM, Jr., Reid B 2013 Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA 310: 797-798
10. Neta G, Rajaraman P, Berrington De Gonzalez A, Doody MM, Alexander BH, Preston D, Simon SL, Melo D, Miller J, Freedman DM, Linet MS, Sigurdson AJ 2013 A prospective study of medical diagnostic radiography and risk of thyroid cancer. Am J Epidemiol 177: 800-809
11. Franceschi S, Boyle P, Maisonneuve P, La Vecchia C, Burt AD, Kerr DJ, Macfarlane GJ 1993 The epidemiology of thyroid carcinoma. Crit Rev Oncog 4: 25-52
12. Rinaldi S, Lise M, Clavel-Chapelon F, Boutron-Ruault MC, Guillas G, Overvad K, Tjonneland A, Halkjaer J, Lukanova A, Kaaks R, Bergmann MM, Boeing H, Trichopoulou A, Zylis D, Valanou E, Palli D, Agnoli C, Tumino R, Polidoro S, Mattiello A, Bueno-De-Mesquita HB, Peeters PH, Weiderpass E, Lund E, Skeie G, Rodriguez L, Travier N, Sanchez MJ, Amiano P, Huerta JM, Ardanaz E, Rasmuson T, Hallmans G, Almquist M, Manjer J, Tsilidis KK, Allen NE, Khaw KT, Wareham N, Byrnes G, Romieu I, Riboli E, Franceschi S 2012 Body size and risk of differentiated thyroid carcinomas: findings from the EPIC study. Int J Cancer 131: E1004-E1014
13. Dal Maso L, Bosetti C, La Vecchia C, Franceschi S 2009 Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control 20: 75-86
14. Pellegriti G, De Vathaire F, Scollo C, Attard M, Giordano C, Arena S, Dardanoni G, Frasca F, Malandrino P, Vermiglio F, Previtera DM, DAzzo G, Trimarchi F, Vigneri R 2009 Papillary thyroid cancer incidence in the volcanic area of Sicily. J Natl Cancer Inst 101: 1575-1583
15. Heuer C 1997 Modeling of time trends and interactions in vital rates using restricted regression splines. Biometrics 53: 161-177
16. Clayton D, Schifflers E 1987 Models for temporal variation in cancer rates. II: Age-period-cohort models. Stat Med 6: 469-481
17. Armitage P, Doll R 1954 The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 8: 1-12
18. Vaccarella S, Lortet-Tieulent J, Plummer M, Franceschi S, Bray F 2013 Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors. Eur J Cancer 49: 3262-3273
19. Vaccarella S, Franceschi S, Engholm G, Lonnberg S, Khan S, Bray F 2014 50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence. Br J Cancer 111: 965-969
20. Parkin DM, Nguyen-Dinh X, Day NE 1985 The impact of screening on the incidence of cervical cancer in England and Wales. Br J Obstet Gynaecol 92: 150-157
21. Efron B, Tibshirani R 1986 Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci 1: 54-77
22. Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, Zhang Y, Bai Y, Zhu C, Guo GL, Rothman N, Zhang Y 2009 International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control 20: 525-531
23. Pike MC, Pearce CL, Wu AH 2004 Prevention of cancers of the breast, endometrium and ovary. Oncogene 23: 6379-6391
24. Plummer M, Peto J, Franceschi S 2012 Time since first sexual intercourse and the risk of cervical cancer. Int J Cancer 130: 2638-2644
25. Rinaldi S, Plummer M, Biessy C, Tsilidis KK, Ostergaard JN, Overvad K, Tjonneland A, Halkjaer J, Boutron-Ruault MC, Clavel-Chapelon F, Dossus L, Kaaks R, Lukanova A, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Agnoli C, Tumino R, Vineis P, Panico S, Bueno-De-Mesquita HB, Peeters PH, Weiderpass E, Lund E, Quiros JR, Agudo A, Molina E, Larranaga N, Navarro C, Ardanaz E, Manjer J, Almquist M, Sandstrom M, Hennings J, Khaw KT, Schmidt J, Travis RC, Byrnes G, Scalbert A, Romieu I, Gunter M, Riboli E, Franceschi S 2014 Thyroidstimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study. J Natl Cancer Inst 106: dju097
26. Negri E, Dal Maso L, Ron E, La Vecchia C, Mark SD, Preston-Martin S, McTiernan A, Kolonel L, Yoshimoto Y, Jin F, Wingren G, Rosaria GM, Hardell L, Glattre E, Lund E, Levi F, Linos D, Braga C, Franceschi S 1999 A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control 10: 143-155
27. Zimmermann MB, Boelaert K 2015 Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol 3: 286-295
28. Harach HR, Franssila KO, Wasenius VM 1985 Occult papillary carcinoma of the thyroid. A normal finding in Finland. A systematic autopsy study. Cancer 56: 531-538
29. Lee YS, Lim H, Chang HS, Park CS 2014 Papillary thyroid microcarcinomas are different from latent papillary thyroid carcinomas at autopsy. J Korean Med Sci 29: 676-679
30. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice JD Jr 1995 Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141: 259-277
31. United Nations Scientific Committee on the Effects of Atomic Radiation 2010 Sources and effects of ionizing radiation, UNSCEAR 2008 Report to the General Assembly with Scientific Annexes. Vol. 1. United Nations, New York
32. Mathews JD, Forsythe AV, Brady Z, Butler MW, Goergen SK, Byrnes GB, Giles GG, Wallace AB, Anderson PR, Guiver TA, McGale P, Cain TM, Dowty JG, Bickerstaffe AC, Darby SC 2013 Cancer risk in 680, 000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ 346: f2360
33. Kitahara CM, Platz EA, Park Y, Hollenbeck AR, Schatzkin A, Berrington De González A 2012 Body fat distribution, weight change during adulthood, and thyroid cancer risk in the NIH-AARP Diet and Health Study. Int J Cancer 130: 1411-1419
34. Minelli G, Conti S, Manno V, Olivieri A, Ascoli V 2013 The geographical pattern of thyroid cancer mortality between 1980 and 2009 in Italy. Thyroid 23: 1609-1618
35. World Health Organization, UNICEF 2007 Iodine Deficiency in Europe: A Continuing Public Health Problem. World Health Organization, Geneva, Switzerland
36. Catelinois O, Verger P, Colonna M, Rogel A, Hemon D, Tirmarche M 2004 Projecting the time trend of thyroid cancers: its impact on assessment of radiation-induced cancer risks. Health Phys 87: 606-614
37. Morris LG, Sikora AG, Tosteson TD, Davies L 2013 The increasing incidence of thyroid cancer: the influence of access to care. Thyroid 23: 885-891
38. Nagar S, Aschebrook-Kilfoy B, Kaplan EL, Angelos P, Grogan RH 2014 Age of diagnosing physician impacts the incidence of thyroid cancer in a population. Cancer Causes Control 25: 1627-1634
39. Pelizzo MR, Rubello D, Bernardi C, Gemo G, Bertazza L, Schievano E, Fedeli U 2014 Thyroid surgical practices shaping thyroid cancer incidence in North-Eastern Italy. Biomed Pharmacother 68: 39-43
40. Zevallos JP, Hartman CM, Kramer JR, Sturgis EM, Chiao EY 2015 Increased thyroid cancer incidence corresponds to increased use of thyroid ultrasound and fine-needle aspiration: a study of the Veterans Affairs health care system. Cancer 121: 741-746
41. Hanley JP, Jackson E, Morrissey LA, Rizzo DM, Sprague BL, Sarkar IN, Carr FE 2015 Geospatial and temporal analysis of thyroid cancer incidence in a rural population. Thyroid 25: 812-822
42. Li N, Du XL, Reitzel LR, Xu L, Sturgis EM 2013 Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980-2008. Thyroid 23: 103-110
43. Reitzel LR, Nguyen N, Li N, Xu L, Regan SD, Sturgis EM 2014 Trends in thyroid cancer incidence in Texas from 1995 to 2008 by socioeconomic status and race/ethnicity. Thyroid 24: 556-567
44. Guay B, Johnson-Obaseki S, McDonald JT, Connell C, Corsten M 2014 Incidence of differentiated thyroid cancer by socioeconomic status and urban residence: Canada 1991-2006. Thyroid 24: 552-555
45. Udelsman R, Zhang Y 2014 The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds. Thyroid 24: 472-479
46. Aschebrook-Kilfoy B, Schechter RB, Shih YC, Kaplan EL, Chiu BC, Angelos P, Grogan RH 2013 The clinical and economic burden of a sustained increase in thyroid cancer incidence. Cancer Epidemiol Biomarkers Prev 22: 1252-1259
47. McLeod DS, Sawka AM, Cooper DS 2013 Controversies in primary treatment of low-risk papillary thyroid cancer. Lancet 381: 1046-1057
48. Franceschi S, Wild CP 2013 Meeting the global demands of epidemiologic transition - the indispensable role of cancer prevention. Mol Oncol 7: 1-13